{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Monkeypox Virus: 2022 Outbreak Clinical Considerations and Stigma

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the appropriate assessment guidelines for monkeypox.
  2. Choose the correct information to give patients about prevention and treatment.
  3. Define the elements of stigma associated with monkeypox.
  4. Select the appropriate actions for educating individuals about monkeypox.

Learning Outcomes

Seventy-five percent of participants will demonstrate competency in clinical reasoning regarding the 2022 monkeypox virus outbreak and its associated stigma by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $29.95

Credits:

  • ANCC 3.5 CH
  • DC - BON 3.5 CH
  • FL - BON 3.5 CH
  • GA - BON 3.5 CH
  • NM - BON 3.5 CH
  • SC - BON 3.5 CH
  • WV - BOERN 3.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: JANAC1122
Published: Nov/Dec 2022
Expires: 9/5/2025
Required Passing Score: 16/20 (80%)
Authors: Jeffrey Kwong, DNP, MPH, ANP-BC, ACRN, FAAN, FAANP; Katherine C. McNabb, MSN, RN, ACRN; Joachim G. Voss, Ph.D., RN, ACRN, FAAN; Alanna Bergman, MSN, AGNP-BC, AAHIVS; Kara McGee, DMS, MSPH, PA-C, AAHIVS; Jason Farley, PhD, MPH, ANP-BC, AACRN, FAAN, FAANP;